News and Views

Nurse Well-Being

It’s Okay to Put Yourself First Sometimes

Are you at—or well over—the brink of burnout? Do you feel like you give, give, give and cannot find the time to refill? Those are common feelings for nurses, whose profession is a service to humanity. Although our work is rewarding, it’s also physically, emotionally, and mentally draining. Never feel guilty or judge yourself for stepping away and taking time for yourself—it’s essential to maintain the high level of care you provide every day.

August 26, 2021

Trending Topics

View All Topics

FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma

August 26, 2021

Testicular Cancer Treatment and Survival Rates Are Improving

Cancer Research

Testicular Cancer Treatment and Survival Rates Are Improving

August 25, 2021

FDA Grants Full Approval for First COVID-19 Vaccine

U.S. Food and Drug Administration (FDA)

FDA Grants Full Approval for First COVID-19 Vaccine

August 25, 2021

Oncology Drug Reference Sheet: Tivozanib

Drug Reference Sheets

Oncology Drug Reference Sheet: Tivozanib

August 24, 2021

American Academy of Nursing Inducts Nine ONS Members as 2021 Fellows

American Academy of Nursing Inducts 10 ONS Members as 2021 Fellows

August 23, 2021

FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma

August 23, 2021

Nursing Representation Is Critical in All Industries—Even Those Outside of Health Care

Nurse Empowerment

Nursing Representation Is Critical in All Industries—Even Those Outside of Health Care

August 20, 2021

FDA Expands Recall to Include Four Additional Lots of Varenicline Tablets Because of N-Nitroso Varenicline Content

U.S. Food and Drug Administration (FDA)

FDA Expands Recall to Include Four Additional Lots of Varenicline Tablets Because of N-Nitroso Varenicline Content

August 19, 2021

FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumors

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumors

August 18, 2021

Whole-Genome Sequencing May Guide Treatment Choices for AML and MDS

Genetics & Genomics

Whole-Genome Sequencing May Guide Treatment Choices for AML and MDS

August 18, 2021

FDA Approves Lenvatinib and Pembrolizumab for Advanced Renal Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Lenvatinib and Pembrolizumab for Advanced Renal Cell Carcinoma

August 13, 2021

FDA Approves Belzutifan for Cancers Associated With Von Hippel-Lindau Disease

U.S. Food and Drug Administration (FDA)

FDA Approves Belzutifan for Cancers Associated With Von Hippel-Lindau Disease

August 13, 2021

Baxter Healthcare Recalls Dose IQ Software Version 9.0.x Because of Software Defect

U.S. Food and Drug Administration (FDA)

Baxter Healthcare Recalls Dose IQ Software Version 9.0.x Because of Software Defect

August 13, 2021

FDA Announces Recall for SterRX, LLC, Sodium Bicarbonate in 5% Dextrose Injection Because of Microbial Contamination

U.S. Food and Drug Administration (FDA)

FDA Announces Recall for SterRX, LLC, Sodium Bicarbonate in 5% Dextrose Injection Because of Microbial Contamination

August 12, 2021

APRN Leaders Mentor Students to Tackle Clinical Practice Issues

Advanced Practice Nursing (APRN)

APRN Leaders Mentor Students to Tackle Clinical Practice Issues

August 12, 2021

Researchers Tie More Cancers, Mortality to NF1 Disorders

Cancer Research

Researchers Tie More Cancers, Mortality to NF1 Disorders

August 11, 2021

Coaching Roles Give Nurses New Avenues to Provide Patient-Centered Care

Oncology Nurse Influence

Coaching Roles Give Nurses New Avenues to Provide Patient-Centered Care

August 10, 2021

ONS Evaluates Educational Funding Landscape

ONS Board of Directors

ONS Evaluates Educational Funding Landscape

August 09, 2021

Nursing Considerations for Lung Cancer Survivorship Care

Survivorship Care Plans

Nursing Considerations for Lung Cancer Survivorship Care

August 05, 2021

Heart Failure May Increase Risk for Certain Cancers

Heart Failure May Increase Risk for Certain Cancers

August 04, 2021

Nursing Informaticists Are the Backbone of Technology-Driven Care

Oncology Nursing Roles

Nursing Informaticists Are the Backbone of Technology-Driven Care

August 03, 2021

Beyond the Bedside: Oncology Nurses Have Endless Opportunities in Unexpected Careers

Clinical Practice

Beyond the Bedside: Oncology Nurses Have Endless Opportunities in Unexpected Careers

August 03, 2021

We Don’t Have a Crystal Ball, but ONS Is Prepared for Nursing’s Future

We Don’t Have a Crystal Ball, but ONS Is Prepared for Nursing’s Future

August 02, 2021

Oncology Nursing Society Response to Mandated COVID-19 Vaccinations for Nurses and All Healthcare Professionals

ONS Response to Mandated COVID-19 Vaccinations for Nurses and All Healthcare Professionals

FDA Alerts About Possible Increased Risk of Death Associated With Melphalan Flufenamide

U.S. Food and Drug Administration (FDA)

FDA Alerts About Possible Increased Risk of Death Associated With Melphalan Flufenamide

The Seven Dimensions of Rest

Nurse Well-Being

The Seven Dimensions of Rest

New Form of CAR T Cells May Target Genetic Alteration Common to All Cancers

New Form of CAR T Cells May Target Genetic Alteration Common to All Cancers

FDA Approves Pembrolizumab for High-Risk, Early-Stage, Triple-Negative Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for High-Risk, Early-Stage, Triple-Negative Breast Cancer

Oncology Drug Reference Sheet: Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf Subcutaneous Injection

Drug Reference Sheets

Oncology Drug Reference Sheet: Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf Subcutaneous Injection

What Is CRISPR?

What Is CRISPR?

FDA Grants Regular Approval to Pembrolizumab and Lenvatinib for Advanced Endometrial Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Pembrolizumab and Lenvatinib for Advanced Endometrial Carcinoma

FDA Announces Recall for 12 Lots of Varenicline Tablets Because of N-Nitroso Varenicline Content

U.S. Food and Drug Administration (FDA)

FDA Announces Recall for 12 Lots of Varenicline Tablets Because of N-Nitroso Varenicline Content

FDA Announces Recall of One Lot of Topotecan Injection Because of Presence of Particulate Matter

U.S. Food and Drug Administration (FDA)

FDA Announces Recall of One Lot of Topotecan Injection Because of Presence of Particulate Matter

ONS Virtual Conference Offers Live and On-Demand Content for Oncology Nurses

ONS Virtual Conference Offers Live and On-Demand Content for Oncology Nurses

Scientists Identify Protein Implicated in Tumor Growth, Treatment Resistance

Cancer Research

Scientists Identify Protein Implicated in Tumor Growth, Treatment Resistance

The Case of the Mysterious Myalgia

The Case of the Mysterious Myalgia

FDA Approves Belumosudil for Chronic Graft-Versus-Host Disease

U.S. Food and Drug Administration (FDA)

FDA Approves Belumosudil for Chronic Graft-Versus-Host Disease

Meet Your ONS Leader: Valerie Burger

Meet Your ONS Leader: Valerie Burger

Diagnose and Treat Hypercalcemia of Malignancy

Advanced Practice Nursing (APRN)

Diagnose and Treat Hypercalcemia of Malignancy

New Evidence-Based Practice Learning Library Now Available

New Evidence-Based Practice Learning Library Now Available

Long-Term irAEs From Checkpoint Inhibitors Have Considerations for Survivorship

Long-Term irAEs From Checkpoint Inhibitors Have Considerations for Survivorship

Nurse Research AIMS to Increase Screening for Malnutrition and Reduce Bowel Dysfunction

Oncology Nurse Researcher

Nurse Researcher AIMS to Increase Screening for Malnutrition and Reduce Bowel Dysfunction

The Evidence Is Building for ACE Inhibitors in Anthracycline-Associated Cardiotoxicity

The Evidence Is Building for ACE Inhibitors in Anthracycline-Associated Cardiotoxicity

FDA Approves Daratumumab and Hyaluronidase-Fihj With Pomalidomide and Dexamethasone for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Daratumumab and Hyaluronidase-Fihj With Pomalidomide and Dexamethasone for Multiple Myeloma

Leadership, Goals, and Missions Drive ONS’s Work

Leadership, Goals, and Missions Drive ONS’s Work

FDA Grants Regular Approval to Enfortumab Vedotin-Ejfv for Locally Advanced or Metastatic Urothelial Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Enfortumab Vedotin-Ejfv for Locally Advanced or Metastatic Urothelial Cancer

Nursing Considerations for Ovarian Cancer Survivorship Care

Nursing Considerations for Ovarian Cancer Survivorship Care

Genetic Disorder Reference Sheet: MUTYH-Associated Polyposis

Genetics & Genomics

Genetic Disorder Reference Sheet: MUTYH-Associated Polyposis

Standard Minimum Nurse-to-Patient Ratio Improves Outcomes

Clinical Practice

Standard Minimum Nurse-to-Patient Ratio Improves Outcomes

Back to Top ▲